Start date
|
End date
|
Designation
|
Funding Agency
|
| 1-2-2013 |
30-6-2013 |
Effects of an algal extract/fruit oils on longevity and obesity phenotypes using the model organism Caenorhabditis elegans (ACRONYM POLINAT 2013) (1784/0151). |
POLIFENOLES NATURALES, S.L. (POLINAT) |
| 1-1-2011 |
30-12-2011 |
Effects of the ptobiotic VSL 3 on experimental intestinal colitis-associated carcinogenesis (1058/0151) |
Actial Farmacéutica |
| 30-11-2009 |
30-6-2011 |
Production and assessment of bimass from microalgae; Sub-project A-6-3. Study to obtain and evaluate natural products from waste biomass: pharmaceutical uses (0632/0151). |
BIOTECNOLOGÍA DE MICROALGAS, S.L. |
| 1-10-2008 |
30-6-2009 |
Study to obtain and recover biomass from microalgae (0245/0151) |
Aurantia 2003, S.L. |
| 17-7-2002 |
18-12-2002 |
Immunohistochemical and molecular study of the regulatory factors of angiogenesis, proliferation and apoptosis in a model of experimental chronic ulcer (OG-121/02). |
Zambon, S.A. |
| 1-12-2000 |
1-12-2001 |
Effects of ibuprofen – L-Arginine and Rocecoxib, the COX inhibitor on lesions previously induced in the rat chronically with hydrochloric acid (OG-007/01). |
Zambon, S.A. |
